- News Home
17 April 2014 12:48 pm ,
Vol. 344 ,
Officials last week revealed that the U.S. contribution to ITER could cost $3.9 billion by 2034—roughly four times the...
An experimental hepatitis B drug that looked safe in animal trials tragically killed five of 15 patients in 1993. Now,...
Using the two high-quality genomes that exist for Neandertals and Denisovans, researchers find clues to gene activity...
A new report from the Intergovernmental Panel on Climate Change (IPCC) concludes that humanity has done little to slow...
Astronomers have discovered an Earth-sized planet in the habitable zone of a red dwarf—a star cooler than the sun—500...
Three years ago, Jennifer Francis of Rutgers University proposed that a warming Arctic was altering the behavior of the...
- 17 April 2014 12:48 pm , Vol. 344 , #6181
- About Us
Robert (Bob) writes about chemistry and materials science, delving into topics ranging from solar energy and fuel cells to proteomics and artificial bone.
Bob majored in psychology and international studies at the University of Oregon. From there he moved on to work on a research project at Oregon Health Sciences University. After a short stint in research, Bob decided he preferred writing about research to actually carrying it out. So it was off to New York University, where he earned a masters degree in journalism at the school’s Science and Environmental Reporting Program.
In the early 1990s, Bob reported for Newsweek, where he covered science and business. In 1994, he moved to Washington, D.C., to join Science. In 1999, he moved to Portland, Oregon, and now helps cover scientific institutions in the western United States. His articles have also appeared in Scientific American and Technology Review, among other publications.
- Most Read
- Most Commented
- 1 week
Breaking news and analysis from the world of science policy